MedAd­vi­sor Thrivor stake

Pharmacy Daily - - Front Page -

LISTED dig­i­tal medicines man­age­ment com­pany MedAd­vi­sor has an­nounced a new part­ner­ship with emerg­ing “soft­ware-as-aser­vice” plat­form Thrivor, as­sist­ing pa­tients and their sup­port net­works when deal­ing with a se­ri­ous ill­ness.

Thrivor com­prises two key com­po­nents: an ad­min­is­tra­tion por­tal to help hospi­tals and clin­i­cal trial sites to man­age com­mu­ni­ca­tions, ap­point­ments and pay­ments; and an app which acts as a sup­port tool for life out­side a pa­tient’s clin­i­cal care.

Un­der the col­lab­o­ra­tion MedAd­vi­sor will re­ceive a 5% stake in Thrivor as an up­front ini­tial fee.

The com­pa­nies said their goals were “highly com­ple­men­tary” in that they sought to lever­age tech­nol­ogy to pro­vide con­ve­nience and im­prove the lives of pa­tients.

The Thrivor app in­cludes func­tion­al­ity to help keep track of med­i­cal ex­penses and records as well as main­tain­ing a health wal­let al­low­ing fam­ily and friends to con­trib­ute fi­nan­cially for pa­tients to pay for ser­vices as re­quired.

Thrivor founder Justin McLean said, “The jour­ney dur­ing se­ri­ous ill­ness of a pa­tient is dis­jointed and in­tim­i­dat­ing,” with the firm’s tech­nol­ogy help­ing ad­dress com­plex is­sues dur­ing this time.

“The Col­lab­o­ra­tion of MedAd­vi­sor and Thrivor plat­forms is a no­brainer to de­liver ben­e­fits for the pa­tient and stake­hold­ers in the health sys­tem,” he said.

MedAd­vi­sor CEO Robert Read said the pact also broad­ened clin­i­cal trial op­por­tu­ni­ties by help­ing iden­tify hard to reach el­i­gi­ble pa­tients and man­age com­pli­ance.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.